198 related articles for article (PubMed ID: 2736531)
1. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.
Capony F; Rougeot C; Montcourrier P; Cavailles V; Salazar G; Rochefort H
Cancer Res; 1989 Jul; 49(14):3904-9. PubMed ID: 2736531
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical significance of cathepsin D in breast cancer metastasis.
Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
[TBL] [Abstract][Full Text] [Related]
3. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.
Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H
Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211
[TBL] [Abstract][Full Text] [Related]
4. Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells.
Freiss G; Vignon F; Rochefort H
Cancer Res; 1988 Jul; 48(13):3709-15. PubMed ID: 2454153
[TBL] [Abstract][Full Text] [Related]
5. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay.
Brouillet JP; Dufour F; Lemamy G; Garcia M; Schlup N; Grenier J; Mani JC; Rochefort H
Cancer; 1997 Jun; 79(11):2132-6. PubMed ID: 9179059
[TBL] [Abstract][Full Text] [Related]
6. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
Rochefort H
C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles.
Montcourrier P; Mangeat PH; Salazar G; Morisset M; Sahuquet A; Rochefort H
Cancer Res; 1990 Sep; 50(18):6045-54. PubMed ID: 2393869
[TBL] [Abstract][Full Text] [Related]
8. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.
Capony F; Braulke T; Rougeot C; Roux S; Montcourrier P; Rochefort H
Exp Cell Res; 1994 Nov; 215(1):154-63. PubMed ID: 7957663
[TBL] [Abstract][Full Text] [Related]
9. Catalytically inactive human cathepsin D triggers fibroblast invasive growth.
Laurent-Matha V; Maruani-Herrmann S; Prébois C; Beaujouin M; Glondu M; Noël A; Alvarez-Gonzalez ML; Blacher S; Coopman P; Baghdiguian S; Gilles C; Loncarek J; Freiss G; Vignon F; Liaudet-Coopman E
J Cell Biol; 2005 Jan; 168(3):489-99. PubMed ID: 15668295
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical significance of cathepsin D in breast cancer.
Rochefort H
Semin Cancer Biol; 1990 Apr; 1(2):153-60. PubMed ID: 2103491
[TBL] [Abstract][Full Text] [Related]
11. The role of cathepsin D in the invasiveness of human breast cancer cells.
Johnson MD; Torri JA; Lippman ME; Dickson RB
Cancer Res; 1993 Feb; 53(4):873-7. PubMed ID: 8428368
[TBL] [Abstract][Full Text] [Related]
12. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
[TBL] [Abstract][Full Text] [Related]
13. Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.
Maudelonde T; Khalaf S; Garcia M; Freiss G; Duporte J; Benatia M; Rogier H; Paolucci F; Simony J; Pujol H
Cancer Res; 1988 Jan; 48(2):462-6. PubMed ID: 3275497
[TBL] [Abstract][Full Text] [Related]
14. Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.
Rochefort H; Augereau P; Briozzo P; Capony F; Cavailles V; Freiss G; Garcia M; Maudelonde T; Morisset M; Vignon F
Biochimie; 1988 Jul; 70(7):943-9. PubMed ID: 3145027
[TBL] [Abstract][Full Text] [Related]
15. [Tumor-associated impairment of the processing of hepatoma cathepsin D].
Maguchi S
Hokkaido Igaku Zasshi; 1988 Jan; 63(1):23-35. PubMed ID: 2834281
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.
Rochefort H; Cavailles V; Augereau P; Capony F; Maudelonde T; Touitou I; Garcia M
J Steroid Biochem; 1989; 34(1-6):177-82. PubMed ID: 2626016
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
18. Controlled production of active cathepsin D in retinal pigment epithelial cells following adenovirus-mediated gene delivery.
Lai CM; Robertson T; Papadimitriou J; Shen WY; Daw N; Constable IJ; Rakoczy PE
Mol Ther; 2000 Nov; 2(5):476-84. PubMed ID: 11082321
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.
Rochefort H; Capony F; Garcia M
Cancer Cells; 1990 Dec; 2(12):383-8. PubMed ID: 1965134
[TBL] [Abstract][Full Text] [Related]
20. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
